Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Epigenetics 
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Home » Events & Conferences » EACR22
EACR22
July 7 - 10, 2012
We would like to welcome you to visit the Tocris Bioscience booth at EACR22 - The European Association for Cancer Research 22nd Biennial Congress in Barcelona, Spain.
Visit booth C2 to learn about our new products and collect free posters. Simply print this page and present it to your Tocris representative for a chance to win a Kindle.
Print off this page and present it to your Tocris respresentative to enter our Kindle prize draw.*
Our staff will take the time to listen to your requirements in order to provide the highest level of customer service, tailored to your research interests.
We look forward to seeing you in Barcelona!
If you have any questions, please do not hesitate to contact us!
Quick Order
Find multiple products by catalog number
New Product E-alerts
Sign up for email updates from Tocris
20% Discount*
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.